Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function

European Journal of Pharmacology

Volumn 393, Issue 1-3, 2000, Pages 113-121

  Marubio, Lisa M ^a   Changeux, Jean Pierre ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Addiction; Ageing; Antinociception; Myasthenic syndrome; Nicotinic acetylcholine receptor; Nicotinic receptor pharmacology

Indexed keywords

ACETYLCHOLINE; ION CHANNEL; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

AGING; ANIMAL MODEL; ANTINOCICEPTION; BEHAVIOR; CENTRAL NERVOUS SYSTEM; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; KNOCKOUT MOUSE; LATENT PERIOD; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RECEPTOR BINDING; SUBSTANTIA NIGRA;

AGING; ANIMALS; FORECASTING; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NICOTINE; PAIN MEASUREMENT; RECEPTORS, NICOTINIC; TOBACCO USE DISORDER;

EID: 0034732231     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00007-8     Document Type: Conference Paper

References (67)

1. Aceto M.D., Bagley R.S., Dewey W.L., Fu T.C., Martin B.R. The spinal cord as a major site for the antinociceptive action of nicotine in the rat. Neuropharmacology. 25:1986;1031-1036.
2. Alkondon M., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265:1993;1455-1473.
3. Bannon A.W., Decker M.W., Holladay M.W., Curzon P., Donnelly-Roberts D., Puttfarcken P.S., Bitner R.S., Diaz A., Dickenson A.H., Porsolt R.D., Williams M., Arneric S.P. Broad-spectrum, non-opiod analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:1998;77-81.
4. Bitner R.S., Nikkel A.L., Curzon P., Arneric S.P., Bannon W., Decker M.W. Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons. J. Neurosci. 18:1998;5426-5432.
5. Capecchi M.R. Altering the genome by homologous recombination. Science. 244:1989;1288-1292.
6. Chappell J., McMahan R., Chiba A., Gallagher M. A re-examination of the role of basal forebrain cholinergic neurons in spatial working memory. Neuropharmacology. 37:1998;481-487.
7. Clarke P.B., Fu D.S., Jakubovic A., Fibiger H.C. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J. Pharmacol. Exp. Ther. 246:1988;701-708.
8. Coleman P.D., Flood D.G. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging. 8:1987;521-545.
9. Conroy W.G., Vernallis A.B., Berg D.K. The alpha 5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain. Neuron. 9:1992;679-691.
10. Corrigall W.A., Cohen K.M., Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653:1994;278-284.
11. Corrigall W.A., Franklin K.B.J., Cohen K.M., Clarke P.B.S. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology. 107:1992;285-289.
12. Couturier S., Bertrand D., Matter J.M., Hernandez M.C., Bertrand S., Millar N., Valera S., Barkas T., Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is blocked by alpha-BTX. Neuron. 5:1990;847-856.
13. Davis L., Pollock L.J., Stone T.T. Visceral pain. Surg. Gynecol. Obstet. 55:1932;418-427.
14. Dineley-Miller K., Patrick J. Gene transcripts for the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system. Brain Res. Mol. Brain Res. 16:1992;339-344.
15. Elrod K., Buccafusco J.J. Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats. J. Pharmacol. Exp. Ther. 258:1991;403-409.
16. Fischbach G.D., Schuetze S.M. A post-natal decrease in acetylcholine channel open time at rat endplates. J. Physiol. 303:1980;125-137.
17. Gallagher M., Colombo P.J. Ageing: the cholinergic hypothesis of cognitive decline. Curr. Opin. Neurobiol. 5:1995;161-168.
18. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 24:1988;19-28.
19. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59:1992;848-856.
20. Grenhoff J., Aston-Jones G., Svensson T.H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol. Scand. 128:1986;351-358.
21. Gu Y., Hall Z.W. Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle. Neuron. 1:1988;117-125.
22. Homanics G., DeLorey T., Firestone L., Quinlan J., Handforth A., Harrison N., Krasowski M., Rick C., Korpi E., Mäkelä R., Brilliant M., Hagiwara N., Ferguson C., Snyder K., Olsen R. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4143-4148.
23. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132:1986;337-338.
24. Iwamoto E.T. Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus. J. Pharmacol. Exp. Ther. 257:1991;120-133.
25. Jurna I., Krauss P., Baldauf J. Depression by nicotine of pain-related nociceptive activity in the rat thalamus and spinal cord. Clin. Pharmacol. 72:1993;65-73.
26. Kasa P., Rakonczay Z., Gulya K. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52:1997;511-535.
27. Kihara T., Shimohama S., Urushitani M., Sawada H., Kimura J., Kume T., Maeda T., Akaike A. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res. 792:1998;331-334.
28. Kutsuwada T., Sakimura K., Manabe T., Takayama C., Katakura N., Kushiya E., Natsume R., Watanabe M., Inoue Y., Yagi T., Aizawa S., Arakawa M., Takahashi T., Nakamura Y., Mori H., Mishina M. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor e2 subunit mutant mice. Neuron. 16:1996;333-344.
29. Le Novère N., Zoli M., Changeux J.P. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8:1996;2428-2439.
30. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
31. Levin E.D., Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology. 138:1998;217-230.
32. Lu Y., Grady S., Marks M.J., Picciotto M., Changeux J.P., Collins A.C. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 287:1998;648-657.
33. Luetje C.W., Patrick J. Both alpha-and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11:1991;837-845.
34. Makela R., Uusi-Oukari M., Homanics G., Quinlan J., Firestone L., Wisden W., Korpi E. Cerebellar gamma-aminobutyric acid type A receptors: pharmacological subtypes revealed by mutant mouse lines. Mol. Pharmacol. 52:1997;380-388.
35. Marin P., Maus M., Desagher S., Glowinski J., Premont J. Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity [see comments]. NeuroReport. 5:1994;1977-1980.
36. Martinou J.C., Merlie J.P. Nerve-dependent modulation of acetylcholine receptor epsilon-subunit gene expression. J. Neurosci. 11:1991;1291-1299.
37. Marubio L.M., Arroyo-Jimenez M.M., Cordero-Erausquin M., Léna C., Le Novère N., Huchet M., Damaj M.I., Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 398:1999;805-810.
38. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
39. McGurk S.R., Levin E.D., Butcher L.L. Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs. Psychopharmacology. 99:1989;371-373.
40. McGurk S.R., Levin E.D., Butcher L.L. Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonists. Neuroscience. 44:1991;137-147.
41. Mishina M., Takai T., Imoto K., Noda M., Takahashi T., Numa S., Methfessel C., Sakmann B. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature. 321:1986;406-411.
42. Missias A.C., Mudd J., Cunningham J.M., Steinbach J.H., Merlie J.P., Sanes J.R. Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an 'adult' acetylcholine receptor subunit. Development. 124:1997;5075-5086.
43. Nisell M., Nomikos G.G., Svesson T.H. Infusion of nicotine in the ventral tegmental area of the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol. Toxicol. 75:1994;348-352.
44. Ohno K., Quiram P., Milone M., Wang H., Harper M., Pruitt J., Brengman J., Pao L., Fischbeck K., Crawford T., Sine S., Engel A. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations. Hum. Mol. Genet. 6:1997;753-766.
45. Ohno K., Wang H., Milone M., Bren N., Brengman J., Nakano S., Quiram P., Pruitt J., Sine S., Engel A. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron. 17:1996;157-170.
46. Orr-Urtreger A., Goldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., Dani J.A., Patrick J.W., Beaudet A.L. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 17:1997;9165-9171.
47. Orr-Urtreger, A., Broide, R.S., Kasten, M.R., Dang, H., Dani, J.A., Beaudet, A.L., Patrick, J.W., in press. Mice homozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within one day of birth. J. Neurochem.
48. Paylor R., Nguyen M., Crawley J.N., Patrick J., Beaudet A., Orr-Urtreger A. Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensimotor gating: a behavioral characterization of acra7-deficient mice. Learning and Memory. 5:1998;302-3016.
49. Piccioto M., Zoli M., Léna C., Bessis A., Lallemand Y., Lenovere N., Vincent P., Merlo-Pich E., Brulet P., Changeux J.-P. Abnormal avoidance learning in mice lacking functional-high affinity nicotine receptor in the brain. Nature. 374:1995;65-67.
50. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature. 391:1998;173-177.
51. Pidoplichko V.I., DeBiasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature. 390:1997;401-404.
52. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 382:1996;255-257.
53. Qian C., Li T., Shen T.Y., Libertine-Garahan L., Eckman J., Biftu T., Ip S. Epibatidine is a nicotinic analgesic. Eur. J. Pharmacol. 250:1993;R13-R14.
54. Ramirez-Latorre J., Yu C.R., Qu X., Perin F., Karlin A., Role L. Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature. 380:1996;347-351.
55. Sakimura K., Kutsuwada T., Ito I., Manabe T., Takayama C., Kushiya E., Yagi T., Aizawa S., Inoue Y., Sugiyama H. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature. 373:1995;151-155.
56. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
57. Siegelbaum S.A., Trautmann A., Koenig J. Single acetylcholine-activated channel currents in developing muscle cells. Dev. Biol. 104:1984;366-379.
58. Spande T.F., Garraffo H.M., Edwards M.W., Yeh H.J.C., Pannel L., Daly J.W. Epibatidine: a novel (chloropyridyl)azabicycloheptaine with potent analgesic activity from an Ecuadoran poison frog. J. Am. Chem. Soc. 114:1992;3475-3478.
59. Tsien J., Huerta P., Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell. 87:1996;1327-1338.
60. Vetter D.E., Liberman M.C., Mann J., Barhanin J., Boulter J., Brown M.C., Saffiote-Kolman J., Heinemann S.F., Elgoyhen A.B. Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation. Neuron. 23:1999;93-103.
61. Villarroel A., Sakmann B. Calcium permeability increase of endplate channels in rat muscle during postnatal development. J. Physiol. 496:1996;331-338.
62. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284:1989;314-335.
63. Wang F., Gerzanich V., Wells G.B., Anand R., Peng X., Keyser K., Lindstrom J. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J. Biol. Chem. 271:1996;17656-17665.
64. Witzemann V., Schwarz H., Koenen M., Berberich C., Villarroel A., Wernig A., Brenner H.R., Sakmann B. Acetylcholine receptor epsilon-subunit deletion causes muscle weakness and atrophy in juvenile and adult mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;13286-13291.
65. Xu W., Gelber S., Orr-Urtreger A., Armstrong D., Lewis R.A., Ou C.N., Patrick J., Role L., De Biasi M., Beaudet A.L. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 96:1999;5746-5751.
66. Zoli M., Léna C., Picciotto M.R., Changeux J.P. Identification of four classes of brain nicotinic receptors using beta-2 mutant mice. J. Neurosci. 18:1998;4461-4472.
67. Zoli M., Picciotto M., Ferrair R., Cocchi D., Changeux J. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO J. 18:1999;1235-1244.